Page 2 - ஒன்றுபட்டது கிஂக்டம் மார்க் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
UK Study Demonstrates the Benefit of Radiosensitizers in Cancer Treatment
uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
UK HealthCare Ranks No 1 in Kentucky, Cancer Care Again Ranks Nationally in U S News & World Report
uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
Diagnosed With Advanced Colorectal Cancer, Young UK Researcher Fights Back
uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
Research led by Dr. Philip Kern was highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases.
LEXINGTON, Ky. (June 2, 2021) – Research led by University of Kentucky endocrinologist and Center for Clinical & Translational Science director Dr. Philip Kern was recently highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in its 2021 Recent Advances & Emerging Opportunities report. The publication conveys important accomplishments resulting from NIDDK-funded research, as well as the enormous promise this research holds for the future.
Kern’s research demonstrated for the first time that a medication called mirabegron, already FDA-approved to treat overactive bladder, improves multiple measures of glucose metabolism in people who are overweight/obese with insulin resistance by inducing beige fat formation in their white adipose fat tissue. The findings uncover a potential new mechanism for treatment of diabetes.
Representatives from Markey, Meadowview Regional Medical Center, LifePoint Health, and the Maysville community celebrate MRMC s new collaboration with Markey and the expansion of their cancer center.
MAYSVILLE, Ky. (May 20, 2021) – On May 19, Meadowview Regional Medical Center (MRMC), part of LifePoint Health, hosted a ribbon cutting ceremony to mark the expansion of its cancer treatment facilities in Maysville, Ky. and announced its formal collaboration with the University of Kentucky (UK) Markey Cancer Center as part of the UK Markey Cancer Center Affiliate Network (MCCAN). A small group of leaders from the hospital, LifePoint and MCCAN gathered to celebrate the reopening of the facility and launch of the collaboration. The expansion of the cancer treatment facility is made possible by a $7.6 million investment from LifePoint Health.